
Mirum Hits All-Time High - Is There More Upside Ahead?
Mirum Pharmaceuticals Inc. (MIRM) has kicked off the year with commercial growth and successful pipeline milestones, propelling its shares to an all-time high of $53. The company has three approved ultra-rare medicines and 4 clinical programs. Its marketed …